Costello Medical were delighted to have a team of 18 colleagues attend ISPOR Europe 2023 in Copenhagen, Denmark this November – our biggest ever delegation!
The agenda this year provided the sense of a threshold moment for HEOR, with the arrival in force of transformative and wide-reaching topics: artificial intelligence (AI) in HEOR; the impending European Union (EU) Joint Clinical Assessment (JCA) process; and the EU Commission’s new legislative proposal for pharmaceutical regulation. There has been some coverage of these topics previously, but this year saw these themes, alongside the ever-present real-world evidence (RWE), dominate the agenda. It was also notable to see the discussion of these topics move from the theoretical to the practical, reflecting the need for all parts of the HEOR community to prepare for these developments that will have a huge impact on the nature of HEOR for years to come. Combined with a record attendance for an ISPOR conference (>5,600 delegates!), this created a real buzz around the Bella Center.
There was, of course, plenty more on the conference agenda besides AI, JCA and RWE, with breakout sessions, podium presentations and posters providing updates on cutting-edge methods in HEOR and latest insights into market access policy for pharmaceuticals and MedTech. We were pleased to contribute 9 research posters of our own to the conference (please see here for these and our other published research).
Our conference attendees have prepared commentaries on a variety of specific topics from the conference at the following links. We hope you enjoy reading them!
The EU Joint Clinical Assessment – Ready or Not, Here it Comes…
Rare Diseases at a European Crossroads: Which Way Forwards for Patients?
Value Assessment Frameworks Fit For the Digital Age
What is a Digital Health Technology? The PICOTS-ComTeC Framework Could Set the Standard
The Future Trajectory for RWE in European Healthcare Decision-Making
AI in HEOR: Pathways, Challenges and Future Directions
The Promise and Pitfalls of Generative AI for Health Economics
The Ongoing Challenges of Immature Data
Advancement of Statistical Methods to Overcome Evidence Gaps
Environmental Responsibility and Patient Voice in Access and HEOR
If you would like any further information about our presence at ISPOR Europe 2023 and learnings from attending the conference, please do not hesitate to contact Matt Griffiths, Global Head of HTA (LinkedIn).
